Inactive on SAM.gov — responses were due 21 Aug 2026 · Small Business Set Aside - Total · Food and Drug Administration (FDA), HHS · College Park, MD · NAICS 325120 · Solicitation RFQ-FDA-134493
Following NAICS 325120? Get new solicitations in it by email as they post — no account needed.
SAM.gov marked this notice inactive — responses were due 21 August 2026.
No award notice on SAM.gov yet. Not every award is posted there, so this does not mean it went unawarded.
Email me when the award is announced. One email, when SAM.gov posts the award notice. Not every award is posted there; if none appears within six months we'll tell you and stop. No account needed.
Can be bid as a nonmanufacturer: 500 or fewer employees, normally sells this item, takes possession of it, and supplies a product made in the US by a small manufacturer unless SBA has waived that. 13 CFR 121.406(b)
This one has closed. We'll email you when new NAICS 325120 (Industrial Gas Manufacturing) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.
Description
The U.S. Food and Drug Administration (FDA), Human Foods Program (HFP), Office of Laboratory Operations and Applied Science (OLOAS), requires weekly delivery of dry ice to support laboratory testing, scientific research, regulatory activities, and other mission-critical laboratory operations across multiple HFP offices. See details of requirements in RFQ and Attachment 1 (PWS). ****************************************************************************** Amendment 0001: The purpose of this amendment 0001 to RFQ is: 1. Amend RFQ by adding Section 4: Section 4 Points of Contact Contracting Officer (CO): Name: Sarah Hussain Email: sarah.hussain@fda.hhs.gov Phone: 301-796-3940 2. Amend RFQ Section 7: Correct Questions Due: From: June 18, 2026 at 10 AM EST To: August 12, 2026 at 3 PM EST No further questions will be answered after the deadline. An amendment to the RFQ will be issued to provide the Government responses to the questions. Except as amended herein, all terms and conditions of solicitation RFQ-FDA-134493 remain unchanged and in full force and effect. Secondary point of contact added Contract Specialist: Aarati Singal; Email: aarati.singal@fda.hhs.gov, please copy Contract Specialist (CS) and CO in any questions/offers submitted in response to this RFQ. ***************************************************************************** Amendment 0002: Cancellation of Solicitation Solicitation No.: RFQ-FDA-134493 Effective Date: August 21, 2026 Issued By: U.S. Food and Drug Administration Contracting Officer: Name: Sarah Hussain Email: sarah.hussain@fda.hhs.gov Phone: 301-796-3940 Section 1: Description The purpose of Amendment 0002 to RFQ-FDA-134493 is to cancel the solicitation in its entirety, effective immediately. No further quotations will be solicited, accepted, or evaluated under this solicitation number, and no award will be made under RFQ-FDA-134493. Section 2: Basis for Cancellation The Government has determined that cancellation of this solicitation is appropriate for two reasons: (1) the requirement, as written, requires further internal review and revision before it can be competed; and (2) proceeding to award under the solicitation as currently written would not be in the Government's best interest. This cancellation is issued under the Government's right, reserved at RFO 52.212-1(d), Instructions to Offerors Commercial Products and Commercial Services, to reject any or all offers when such action is in the public interest. No purchase order or contract has been awarded or accepted under this solicitation. Section 3: Effect on Offerors Any quotations already submitted in response to RFQ-FDA-134493 will not be evaluated and will not result in award. No further action by offerors is required. Offerors will not be charged any fee or penalty as a result of this cancellation, and the Government assumes no liability for costs incurred by offerors in preparing or submitting quotations. Except as cancelled herein, this notice supersedes RFQ-FDA-134493 and Amendment 0001 in their entirety. No further amendments, questions and answers, or solicitation actions will be issued under solicitation number RFQ-FDA-134493.
Version history
SAM.gov has posted 4 notices under solicitation RFQ-FDA-134493, oldest first.
FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.
Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.
